These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 12971801)
1. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid. Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801 [TBL] [Abstract][Full Text] [Related]
2. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid. Wang YP; Yan J; Fu PP; Chou MW Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625 [TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of pyrrolizidine alkaloid-derived DNA adducts in vitro and in vivo. Fu PP; Chou MW; Churchwell M; Wang Y; Zhao Y; Xia Q; Gamboa da Costa G; Marques MM; Beland FA; Doerge DR Chem Res Toxicol; 2010 Mar; 23(3):637-52. PubMed ID: 20078085 [TBL] [Abstract][Full Text] [Related]
4. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine. Xia Q; Yan J; Chou MW; Fu PP Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999 [TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts. Yan J; Xia Q; Chou MW; Fu PP Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697 [TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo. Wang YP; Yan J; Beger RD; Fu PP; Chou MW Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930 [TBL] [Abstract][Full Text] [Related]
7. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine. Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839 [TBL] [Abstract][Full Text] [Related]
8. Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. Xia Q; Chou MW; Kadlubar FF; Chan PC; Fu PP Chem Res Toxicol; 2003 Jan; 16(1):66-73. PubMed ID: 12693032 [TBL] [Abstract][Full Text] [Related]
9. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity. Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665 [TBL] [Abstract][Full Text] [Related]
10. Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation. Zhao Y; Xia Q; Gamboa da Costa G; Yu H; Cai L; Fu PP Chem Res Toxicol; 2012 Sep; 25(9):1985-96. PubMed ID: 22857713 [TBL] [Abstract][Full Text] [Related]
11. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Chou MW; Wang YP; Yan J; Yang YC; Beger RD; Williams LD; Doerge DR; Fu PP Toxicol Lett; 2003 Dec; 145(3):239-47. PubMed ID: 14580895 [TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo. Wang YP; Fu PP; Chou MW Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803 [TBL] [Abstract][Full Text] [Related]
13. 7-cysteine-pyrrole conjugate: A new potential DNA reactive metabolite of pyrrolizidine alkaloids. He X; Xia Q; Ma L; Fu PP J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016; 34(1):57-76. PubMed ID: 26761716 [TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo. Yang YC; Yan J; Doerge DR; Chan PC; Fu PP; Chou MW Chem Res Toxicol; 2001 Jan; 14(1):101-9. PubMed ID: 11170513 [TBL] [Abstract][Full Text] [Related]
15. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry. Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436 [TBL] [Abstract][Full Text] [Related]
16. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation. Xia Q; He X; Ma L; Chen S; Fu PP Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181 [TBL] [Abstract][Full Text] [Related]
17. Reaction of dehydropyrrolizidine alkaloids with valine and hemoglobin. Zhao Y; Wang S; Xia Q; Gamboa da Costa G; Doerge DR; Cai L; Fu PP Chem Res Toxicol; 2014 Oct; 27(10):1720-31. PubMed ID: 25211425 [TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts. Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804 [TBL] [Abstract][Full Text] [Related]
19. Development of a (32)P-postlabeling/HPLC method for detection of dehydroretronecine-derived DNA adducts in vivo and in vitro. Yang Y; Yan J; Churchwell M; Beger R; Chan P; Doerge DR; Fu PP; Chou MW Chem Res Toxicol; 2001 Jan; 14(1):91-100. PubMed ID: 11170512 [TBL] [Abstract][Full Text] [Related]
20. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts. Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]